Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare Plans

Rolin L. Wade; Chi-Chang Chen; Ajita P. De; Jaren C. Howard

doi:10.36469/9800

Loading [Contrib]/a11y/accessibility-menu.js

Methodology and Healthcare Policy

Vol. 5, Issue 1, 2017

July 11, 2017 EDT

Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare Plans

Rolin L. Wade, Chi-Chang Chen, Ajita P. De, Jaren C. Howard,

health plans healthcare costs utilization management formulary restrictions oxycodone hcl extended release opioids

ccby-4.0

• https://doi.org/10.36469/9800

Photo by Dmitry Bayer on Unsplash

JHEOR

Wade RL, Chen CC, De AP, Howard JC. Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare Plans. JHEOR. 2017;5(1):75-88. doi:10.36469/9800

View more stats